Ti-Touch – Finally, Titration Reduced to the Max

Laboratory products

Ti-Touch – Finally, Titration Reduced to the Max

28 Nov, 2011

Published over 14 years ago. See the latest and most current information on Laboratory products.

Metrohm is pleased to introduce the Ti-Touch, the new compact titrator for routine analysis. The Ti-Touch, which is available for Karl Fischer titration (915 KF Ti-Touch) and potentiometric titration (916 Ti-Touch), sets the new standard for stand-alone titrators. The key-features and user benefits speak for themselves!

Burette, stirrer, dosing system and Touch Control module are cased in a single, compact unit. Waste of valuable bench space is avoided.

With the Ti-Touch users can generate paperless, forge-proof PDF reports – without a PC. Any data generated (methods & results) can be sent directly to the LIMS or intranet and managed there. Moreover, the Ti-Touch features a USB interface, so users can simply plug in a printer, USB stick or barcode reader.

Due to the 800 Dosino with its patented top-down dosing principle, the Ti-Touch enables contact-free exchange of KF reagents.

Up to 14 methods can each be linked to a favourite icon on the brilliant touch screen. Methods start at a single touch!

Straightforward automation, plug-and-play functionality, self-monitoring of the system components and results round off the Ti-Touch’s key features. These features combined make the Ti-Touch the most powerful stand-alone titrator available in the market.

For more information visit www.metrohm.co.uk

Latest News

Lab Asia 33.4 - August 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
FM approval strengthens intelligent fixed gas detection for refineries and petrochemical plants
Explore more Arrow
Pollution Solutions Online
Slurry grant a fossil fuel failure?
Explore more Arrow
Petro Online
Precision by weight: The critical role of gravimetric blending in fuel certification
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow